Guidance on the safe use of medicines in research and treatment has been issued by the Association of the British Pharmaceutical Industry.
The advice covers what is expected of companies holding innovative or generic marketing authorisations for medicinal products in the European Union.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.